David Currow's guest appearances

David Currow

Nursing Review

GeriPal

Scott Bauer

Julie Henderson

BJ Miller

Sarah Brown

Andy Cohen

Charles Darwin

Michael Ward

Aaron Kesselheim

Dan Woods

Louise Aronson

Bill Bailey

Lee Thomas

Sam Miller

Haider Warraich

Lewis Cohen

OwlTail

Do opioids improve breathlessness? A simple question that unfortunately doesn't seem to have a simple answer. We get into the nitty-gritty of potential answers to this question with a preeminent researcher in this field, David Currow. David is a Professor of Palliative Medicine at University of Technology Sydney. His research has challenged common practices in Hospice and Palliative Care, including randomized control trials on oxygen for breathlessness, octreotide for malignant bowel obstruction, and antipsychotics for delirium in palliative care patients. His most recent study was published in Thorax titled "Regular, sustained-release morphine for chronic breathlessness: a multicentre, double-blind, randomised, placebo-controlled trial." It showed no differences between those that got sustained-release morphine and those that got placebo in regards to breathlessness, but the intervention arm did use less rescue immediate-release morphine. We talk to David about how to interpret these results, as well as what to make out of the broadened inclusion criteria and whether there was an issue with the primary outcome. Other articles we reference in the podcast include: * The safety study: No excess harms from sustained-release morphine: a randomised placebo-controlled trial in chronic breathlessness * And the oxycodone SA study: Controlled-Release Oxycodone vs. Placebo in the Treatment of Chronic Breathlessness-A Multisite Randomized Placebo Controlled Trial. by Eric Widera, @ewidera

Opioids for Breathlessness: A Podcast with David Currow

Chief cancer officer and chief executive of Cancer Institute NSW professor David Currow on the Patient Perspectives report, which is based on results from the Adult Admitted Patient Survey.